Otsuka Pharmaceutical Group

Worldwide

Global Navigation

Go to Primary Contents
Home > News > Worldwide News > News release details

Primary contents

News release details

Otsuka

Otsuka Pharmaceutical Co., Ltd. Appoints
the Board Members and Statutory Auditors

Tokyo, Japan-- Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) announced the appointment of the board members and statutory auditors following approval at the 44th Ordinary General Meeting of Shareholders held on June 25th.

Directors on the Board and Statutory Auditors

The board Members and statutory auditors are as follows. Five Board Members have been newly appointed (*).

Nakaima Okabayashi Chairman
Taro Iwamoto* President, Representative Director
Hiroyoshi Settsu* Vice President, Representative Director
Masayuki Umeno* Vice President (Otsuka International Asia Arab (OIAA) Division)
Hiromi Yoshikawa Managing Director (Accounting, Finance and Business Promotion)
Antoni Villaró Martin* Managing Director (Europe Operations)
Tatsuro Watanabe* Managing Director (Human Resources, Administration,
Legal Affairs and Business Planning Liaison)
Akihiko Otsuka Executive Director
Tatsuo Higuchi Executive Director
Masahiko Kato Standing Statutory Auditor
Isao Otsuka Statutory Auditor
Kazuyoshi Endo Statutory Auditor
Yasuhisa Katsuta Statutory Auditor
↑Back to top

Otsuka - people creating new products for better health worldwide